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ABSTRACT 
 Purpose: Accurate contouring of PET functional volumes is now considered crucial in image-
guided radiotherapy and other oncology applications, as the use of functional imaging allows 
biological target definition. In addition, the definition of variable uptake regions within the tumour 
itself may facilitate dose painting for dosimetry optimization. 
Material and methods: Current state-of-the-art algorithms for functional volume segmentation use 
adaptive thresholding. We have developed an approach named Fuzzy Locally Adaptive Bayesian 
(FLAB), validated on homogeneous objects. We improved it for the delineation of inhomogeneous 
tumours by allowing the use of up to three classes. Simulated and real tumours with histology data 
containing homogeneous and heterogeneous activity distributions were used to assess the algorithm’s 
accuracy.  
Results: The new 3-FLAB algorithm is able to extract the overall tumour from the background tissues, 
as well as delineate variable uptake regions within the tumours, with higher accuracy and robustness 
compared to adaptive threshold (Tbckg) and fuzzy C-means (FCM). 3-FLAB performed with a mean 
classification error of less than 9±8% on the simulated tumours whereas binary-only implementation 
led to errors of 15±11%. Tbckg and FCM lead to mean errors of 20±12% and 17±14% respectively. 3-
FLAB also lead to more robust estimation of the maximum diameters of tumours with histology 
measurements, with less than 6% standard deviation whereas binary FLAB, Tbckg and FCM lead to 
10%, 12% and 13% respectively.  
Conclusion: These encouraging results warrants further investigation in future studies that will 
investigate the impact of 3-FLAB in radiotherapy treatment planning, diagnosis and therapy response 
evaluation 
 
 
Key Words: Heterogeneous functional volumes delineation; automatic segmentation; image-guided 
radiotherapy; dose painting. 
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1. Introduction 
 While most of positron emission tomography (PET) clinical applications rely on manual and 
visual analysis, accurate functional volume delineation in PET is crucial for numerous oncology 
applications. These include the use of tumour volume and associated determination of semi-
quantitative indices of activity concentration for diagnosis and therapy response evaluation (1), or the 
definition of target volumes in intensity-modulated radiation therapy (IMRT) (2). Subjective (1) and 
tedious manual delineation cannot perform accurate and reproducible segmentation especially when 
considering complex shapes and non-homogeneous uptake. This results from the low quality of PET 
images notably due to statistical noise and partial volume effects (PVE) (3) arising from the scanner’s 
limited spatial resolution. 
Most of the previously proposed methods for PET volume definition are semi-automatic and 
threshold-based, using either fixed (30-75% of the maximum activity) (2,4,5) or adaptive approaches 
incorporating the background activity (6-10). Unfortunately, these approaches often require additional 
a priori information and are user- and system-dependent. They require manual background regions of 
interest (ROIs) and their performance depend on parameters requiring optimization using phantom 
acquisitions for each scanner and reconstruction. Finally all of these approaches are strictly binary and 
were not validated considering heterogeneous volumes. 
On the other hand, numerous works have addressed PET lesion segmentation using more 
advanced image segmentation methodologies (11-19). However, the majority of these approaches 
often depend on pre- or post-processing steps like deconvolution and/or denoising, are often binary 
only and validated on phantom acquisitions or clinical data without rigorous ground-truth. 
We have previously developed an algorithm for PET volume definition by combining a fuzzy 
measure with a locally adaptive Bayesian-based classification (FLAB) that has been shown to perform 
better with respect to fixed thresholding, Fuzzy C-Means (FCM) or Fuzzy Hidden Markov Chains 
(FHMC) for PET volume definition, as far as homogeneous spheres or slightly heterogeneous and non 
spherical tumours are concerned (20). Preliminary results show that FLAB is also robust with respect 
to variability of the acquisition and reconstruction parameters (24). 
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Clinical tumours may be characterized by heterogeneous uptake, thus demanding a non-binary 
approach for an accurate segmentation that may have a significant impact in defining biological target 
volumes for dose painting (21). The goals of this work were to (a) improve the FLAB model by 
incorporating the use of three hard classes and three fuzzy transitions and (b) evaluate its accuracy on 
real (with known diameter measured in histology) and simulated (with known ground-truth) datasets 
containing inhomogeneous tumours.  
2. Materials and methods 
2.1 The 3-class fuzzy Bayesian segmentation (3-FLAB) 
 The 3-FLAB algorithm is an extension of the previous work considering only a binary 
segmentation (20). FLAB automatically estimates parameters of interest from the image, maximizing 
the probability of each voxel to belong to one of the considered classes. This probability is estimated 
for each voxel as a function of its value and the values of its neighbours relative to the voxels’ 
statistical distributions in the image which corresponds to an estimation of the noise within each class. 
Hence, each voxel of the volume is considered by the method as a random variable within a Bayesian 
framework: 
(X,Y) (Y | X) (X)(X | Y) (Y) (Y)
P P PP
P P
= =  (1) 
where, (X | Y)P is the probability to belong to class X knowing the observation Y. This probability is 
obtained by the product of (Y | X)P  and (X)P , corresponding to the noise model and the spatial 
model respectively. (Y | X)P  is estimated considering the statistical distribution of the voxels within 
each class, whereas (X)P  is estimated  using a sliding cube of 3x3x3 voxels, hence each voxel’s 
classification is influenced by its neighbours. The parameters to estimate are the mean and variance of 
each class and the spatial probabilities of each voxel with respect to its neighbours. This is performed 
iteratively using a stochastic version (SEM) (25) of the Expectation Maximization (EM) (26) 
initialized with K-Means (27) or Fuzzy C-Means (28). In addition, a fuzzy measure between the 
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classes was added in order to account for the blur between regions, assuming each voxel may contain a 
mixture of classes. 
 The originality of 3-FLAB relative to the previously developed binary-only FLAB (20) is the 
use of three classes and three fuzzy transitions within the model (see fig.1), to deal with both 
homogeneous and heterogeneous activity distributions. Fig.2 demonstrates the inability of FLAB to 
handle highly non-uniform activity distributions, where the lower uptake part of the lesion is 
erroneously considered as part of the background (see fig.2(b)), emphasizing the need to better model 
heterogeneous activity distributions. 3-FLAB should retain the accuracy and robustness of the original 
model, being in addition able to accurately handle challenging heterogeneous activity distributions 
frequently characterizing clinical lesions. The 3-FLAB segmentation workflow is summarized below, 
while the implementation and mathematical details can be found in the Appendix: 
(1). Initialization of both the spatial and noise models parameters. Means and variances of each 
class are obtained using the K-Means or Fuzzy C-Means. The prior probabilities are fixed at 1/3 for 
each class. 
(2). Iterative estimation using the SEM by stochastic sampling for each voxel according to its 
posterior probability. 
(3). Segmentation by selecting for each voxel the class or fuzzy level that maximizes its posterior 
probability and fusion of fuzzy levels with each hard class to generate a 2 or 3 class segmentation 
map. 
 
2.2 Alternative segmentation methodologies used for comparison 
We compared the results of the 3-FLAB algorithm with the binary FLAB approach and the Fuzzy 
C-Means (with 2 or 3 clusters) clustering introduced by Dunn (28) and used to segment PET brain 
tumours in (13), as well as an adaptive thresholding (6) (Tbckg): 
threshold mean backgroundI I Iα= × +   (2) 
meanI  was obtained by computing the mean of all voxels contained inside an initial threshold at 70% of 
the maximum and backgroundI  by computing the mean of the voxels inside a ROI manually drawn on the 
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background. meanI  and backgroundI  were subsequently used to derive a first approximation of the source-
to-background contrast. The parameter α  was optimised using phantom acquisitions on each scanner 
used to obtain the data. The adaptive thresholding algorithm was implemented using a region growing 
approach with the maximum intensity voxel as a seed and iteratively adding 3D-neighbouring voxels 
if their value was above the threshold calculated using equation (2). 
 
2.3 Validation studies 
2.3.1 Datasets 
 Dataset-1 was used to evaluate the performance of the algorithm under realistic imaging 
conditions. It consists of twenty three-dimensional simulated tumours with variable levels of irregular 
shape and homogeneous or non-homogeneous uptake distributions derived from tumours in patients 
undergoing 18F-FDG PET/CT investigations for radiotherapy treatment planning purposes. These 
images were acquired in 2D and 3D mode using the GE Discovery LS and Philips Gemini PET/CT 
scanners respectively. Three of these tumours illustrating the range of sizes, shapes and heterogeneities 
considered are shown in fig.4(a-c). The goal was to produce realistic images of PET tumours while 
retaining a voxel-based ground-truth in order to compute accurate voxel-based classification errors. 
Half of the tumours were simulated considering a homogeneous uptake distribution whereas the other 
half was simulated using significant heterogeneity within the tumour. The procedure followed to 
generate these images is illustrated in fig.3 and is detailed below. 
 Each clinical tumour is first manually delineated on the PET image by a nuclear medicine 
expert, thus creating a voxelized volume that represents the ground-truth of the simulation. The 
activity levels attributed to each of the tumour parts were derived based on the average activity 
measured in the same areas of the tumour in the corresponding patient images. This ground-truth 
tumour structure is subsequently transformed into a Non-Uniform Rational B-Splines (NURBS) 
volume via RhinocerosTM (CADLINK software), for insertion into the NCAT phantom (29) attenuation 
maps at the same approximate position as where it was located in the patient (30). No respiratory or 
cardiac motions were considered. Simulations using a model of the Philips PET/CT scanner previously 
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validated with GATE (Geant4 Application for Tomography Emission) (31) were carried out. A total of 
45 million coincidences were simulated corresponding to the statistics of a clinical acquisition over a 
single axial 18 cm field of view (31). Images were subsequently reconstructed using OPL-EM (7 
iterations, 1 subset) (31) with two different voxel sizes (4x4x4 for the Philips Gemini and 2x2x5 mm3 
for the GE Discovery LS) in order to match those used in the corresponding clinical images.  
 Dataset-2 contains 18 images of lung tumours from patients with histologically proven Non-
Small Cell Lung Cancer (clinical Stage Ib–IIIb), acquired on the Siemens Biograph PET/CT scanner 
and reconstructed using OSEM (4 iterations, 8 subsets), with scatter and CT-based attenuation 
correction, and 5.31x5.31x5.31 mm3 voxels. These tumours were surgically extracted for a histology 
study in which their maximum diameter was measured by macroscopic examination (32). These 
diameters range from 15 to 90 mm (44+/-21). One of these tumours is shown in fig.4(d). 
 
2.3.2 Analysis 
 As our goal is not the detection of a lesion in the whole image but the accurate estimation of 
its volume and shape, we assume it has been detected and isolated by the clinician within a 3-D “box” 
well encompassing the tumour.  
Since a ground-truth was available, Classification Errors (CE) were computed. In the case of a 2-class 
ground-truth, the CE is: 
    
{ }
{ }
|
100| 1
t t
t
card t c x
CE
card t x
≠
= ×
=
     (3) 
where, tc  is the classification of voxel t and tx  is the true class. Card is the number of elements. 
This error measurement takes into consideration the spatial distribution of the tumor by considering 
both background voxels classified as object and object voxels classified as background. Consequently 
this measure is more appropriate than simple volume estimation which could lead to overall small 
volume errors associated with largely inaccurate segmentations. In addition, the errors are computed 
relatively to the size of the object, to avoid biases relative to the size of the processing box. In the case 
of a 3-class ground-truth, CE may be computed for each of the three classes using equation (4) or with 
respect to a binarized ground-truth (2nd and 3rd class merged) using equation (3). 
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where, CEc stands for the Classification Error associated with a given class c.  
 Two different analyses were conducted using dataset-1: The first considered the entire dataset 
(both homogeneous and heterogeneous tumours) and CE computed using equation (3), in order to 
compare overall performances of FLAB (binary only), 3-FLAB, FCM and Tbckg. The second 
considered only the ten heterogeneous tumours to compute CE2 and CE3 using equation (4) for 3-
FLAB and FCM with three clusters. 
 The segmentation accuracy on the tumours with histology (dataset-2) was assessed by 
segmenting the clinical image and subsequently measuring the maximum diameter on the segmented 
volumes, to compare it with the histology measurement. 
3. Results 
 Fig.5 contains one axial slice of the segmentations obtained on three simulated tumours of 
dataset-1 and one tumour of dataset-2. Fig.6(a) contains the mean classification errors and standard 
deviation obtained by all the methods on the 20 tumours of dataset-1. FLAB (binary only) performed 
well on homogeneous tumours but failed as expected on strongly heterogeneous lesions leading to 
overall errors of 15±11%. 3-FLAB on the other hand produced segmentation maps closer to the 
ground-truth, both visually and quantitatively, with errors between 5% and 15% (9±8%). FCM (with 2 
or 3 clusters) was competitive with respect to 3-FLAB for some tumours, but showed a higher 
variability (10-40%) and mean error (20±12%). This translated qualitatively in FCM being unable to 
differentiate two different regions within the tumour as well as being unable to detect discontinuities 
in the contours (e.g. fig.5(d), 1st row). In addition, for the regions where a transition was present 
between the high uptake region and the background (e.g. fig.4(d)) the 3-FLAB approach was the only 
one giving accurate representation of this transition (fig.5(c) versus fig.5(d), last row). Tbckg was not 
able to produce satisfactory segmentation in several cases. Tumours with high overall contrast were 
approximately extracted from the background (e.g. fig.5(e), rows 2-4). However, as a binary method it 
is unable to delineate uptake distributions within the tumour. In several cases the heterogeneity was 
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significant and Tbckg lead to significant under-evaluation of the tumour volume (CE up to 60% with a 
mean of 17%±14%) as it tends to extract the high activity region or parts of the reduced uptake region 
only (e.g. fig.5(e), 1st row). 
 Fig.6(b) compares 3-FCM (using three clusters) and 3-FLAB concerning the three-class 
segmentation of the ten heterogeneous simulated tumours of dataset-1. 3-FCM is less accurate and 
robust compared to 3-FLAB especially in the case of the delineation of higher activity regions (3rd 
class), with about twice the mean error and standard deviation (24±20%) of 3-FLAB (11±8%).  
 Fig.7 contains the mean error and standard deviation with respect to the maximum diameter, 
computed on the tumour histology database (dataset-2). Whereas all methods gave relatively low mean 
errors (<-3%), the standard deviation associated with FCM and Tbckg (13% and 12% respectively) is 
about twice the one of 3-FLAB (<6%), while binary FLAB lead to almost 10% standard deviation. 
The low mean error for all these algorithms is explained by the fact that there were about the same 
amount of under- and over-estimation of the diameters in this dataset, resulting in an overall low mean 
error. The standard deviation is here a better indicator of the accuracy obtained on the dataset and 
demonstrates higher accuracy and robustness for 3-FLAB. 
4. Discussion 
 Functional volume delineation represents today an area of interest for multiple clinical (routine 
and research) applications of PET. Such areas include response to therapy studies and the use of 
biological tumour volumes in radiotherapy treatment planning. Although several fully automatic 
algorithms have been recently proposed (11-20), segmentation methodologies currently used in 
clinical practice are based on the use of fixed and adaptive thresholding (4-10). These algorithms have 
been shown to accurately determine functional volumes under specific imaging conditions of spherical 
and homogeneous activity distribution object in phantom studies, as well as been evaluated on clinical 
images where the ground-truth is unknown. In clinical practice lesions are often heterogeneous in 
shape and uptake. In order to address these issues we have extended a previously developed algorithm 
to accurately handle lesions with non-uniform uptake and non-spherical forms. In addition, we have 
proposed an evaluation framework including both realistic simulated patient lesions and histological 
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assessment of tumour diameters, allowing the evaluation of segmentation algorithms under standard 
imaging conditions with the added advantage of knowing the ground-truth.  
The inability of the adaptive thresholding considered in this study to accurately segment complex 
tumours is demonstrated by its poor performance. This is explained by the fact that in case of 
heterogeneous uptake, the 70% threshold used for the initial estimation of the tumour-to-background 
contrast may retain only the high uptake region, thus leading to incorrect contrast estimation. On the 
other hand, if the lesion is small and/or has a small contrast, the 70% threshold may lead to an initial 
overestimation of the volume of the tumour, hence an underestimation of its uptake and therefore an 
incorrect estimation of the contrast which the subsequent adaptive thresholding may not be able to 
compensate for. In addition, the background ROI is user-dependent with a potentially high impact on 
the result, especially with heterogeneous background. When such a case occurred we systematically 
selected the ROI which resulted in the lowest error. Finally, the region growing implementation avoids 
incorporating false positives of the background if they are not connected to the main tumour, 
especially when the contrast is low and/or if the background is noisy and heterogeneous. However it 
also makes the algorithm dependent on the seed location and can lead to missing parts of the tumour 
when several high uptake regions are connected by low uptake regions. FCM can produce binary or 3-
class segmentations but its robustness and accuracy are much lower compared to FLAB because it 
incorporates neither spatial correlation nor noise modeling. One advantage of the Tbckg over FCM is its 
region growing implementation that makes it less susceptible than FCM to the inclusion of high 
intensity voxels of the background. Therefore FCM usually performs poorer than Tbckg for low contrast 
lesions and noisy images but better for heterogeneous activity distributions within the tumour. On the 
other hand, 3-FLAB performed accurately even under challenging contrast, noise and heterogeneity 
conditions, with overall superior performance than the other algorithms considered here.  
The need for more than three classes may arise for heterogeneous tumours on a heterogeneous 
background. However, all the clinical tumours considered in this study were correctly delineated using 
two or three classes because the contrasts between the heterogeneities within the tumour are usually 
much higher than those occurring in the background, hence only one hard class may be sufficient to 
deal with the background whereas two are required to correctly handle the significantly different 
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uptakes occurring inside the tumour. Eventually the 3-FLAB algorithm could be extended to more 
than three classes assuming that only pairs of hard classes generate fuzzy transitions. One also has to 
keep in mind that using more classes will lead to smaller regions, but those regions within the tumor 
will subsequently be used for quantification or radiotherapy dose boosting and/or painting and should 
therefore be kept reasonably large. The potential impact of using three classes proposed by 3-FLAB 
should therefore be investigated before more complex segmentations using additional classes can be 
considered.  
 We have already demonstrated that FLAB performs well for small lesions down to 13 mm in 
diameter (20) and this study was not designed to specifically investigate the ability of 3-FLAB to deal 
with small tumours since these rarely exhibit heterogeneous uptake that can be detected on the PET 
image considering the existing resolution limits. 3-FLAB retains all the characteristics of FLAB but 
adds the ability to consider a third class and therefore handle non-uniform lesion activity distributions. 
Thus 3-FLAB does not as such improve the delineation of small (<2cm) lesions. However the 
higher/lower uptake regions within the larger tumours are often of small size comparable to that of 
small lesions, with PVE affecting them with respect to their “background” which is in fact the other 
part of the tumour with different uptake. As fig.6(b) demonstrates 3-FLAB is capable to accurately 
segment these regions. 
 An application that could greatly benefit from the use of FLAB is radiotherapy treatment 
planning (33). It is now acknowledged that planning based on PET/CT volumes improves tumour 
delineation by reducing inter- and intra-observer variability (32,34). It can also lead to the inclusion of 
regions not visible on CT, or the exclusion of regions without significant uptake (35). Using the 3-
FLAB algorithm could help lower the inter- and intra-observer variability , as well as shorten the 
overall time consuming delineation process associated with currently implemented algorithms 
considering the need of multiple phantom studies for the use of adaptive thresholding. 3-FLAB takes a 
few seconds per iteration even for the largest tumours considered in this study (on a single 2Ghz core 
processor in C++ implementation).Secondly, “dose painting” can be facilitated considering the non-
binary nature of the proposed segmentation, allowing the automatic definition of ROIs inside the 
tumour, for example in dose escalation studies (36), in addition to the external contour information for 
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optimized dosimetry, potentially reducing the dose delivered to healthy surrounding tissues and 
organs. The impact of such improved accuracy on overall patient’s outcome remains to be 
demonstrated in clinical studies which are planned for the future. Finally, FLAB robustness with 
respect to the noise characteristics associated with the use of different scanners, acquisition protocols 
and reconstruction algorithms have been demonstrated in a preliminary study (24) and should allow its 
use with any type of PET images without the need of time consuming pre-processing optimization.    
 The proposed algorithm may also have an impact in diagnosis and therapy response 
assessment when combined with PVE correction (PVC) for accurate quantification. Considering 
different PVC approaches, anatomical information from MRI or CT is used to improve the 
quantitative and qualitative accuracy of functional images (37,38). Unfortunately, when no anatomical 
image is available or no correlation exists between the anatomical and functional structures, such 
approaches cannot be easily used (3). This is especially true in the case of large heterogeneous 
tumours for which there is little to no correlation between the anatomical and functional information. 
A potential solution will be the use of the FLAB result instead of the anatomical image in combination 
with one of the previously proposed PVC algorithms. This should lead to improved contrast at the 
object’s borders as well as improved quantification in the regions within the tumour. Such 
combination recently demonstrated encouraging results (39) and warrants further investigation in 
terms of the potential impact in clinical therapy response studies. 
 
5. Conclusion 
 A modified version of the FLAB algorithm has been developed in order to include the 
estimation of three hard classes and three fuzzy transitions. This automatic approach combines 
statistical and fuzzy modeling in order to address specific issues such as noise and PVE associated 
with 3D PET images. Its accuracy has been assessed on both simulated and clinical images of complex 
shapes, containing inhomogeneous activities and small regions. The results demonstrate the ability 3-
FLAB to accurately delineate such lesions, for which threshold-based methodologies suggested until 
now fail.  
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Figure Captions 
Figure 1: The fuzzy scheme in the 3-FLAB implementation. 
Figure 2: Binary FLAB model applied to a heterogeneous simulated tumour (a). The segmentation 
result (b) clearly misses parts of the tumour. 
Figure 3: The simulation of realistic PET images. 
Figure 4: Datasets illustration. (a-d) Examples of clinical tumours (up) with CT (left) and PET (right), 
and the corresponding simulated PET (down). (a)-(c) dataset-1; (d) dataset-2.  
Figure 5: Segmentations of the tumours in fig.4(a-d): (a) ground-truth; (b) PET image; (c-d) 
segmentations for (c) 3-FLAB, (d) FCM, (e) Tbckg. 
Figure 6: Mean Classification Errors and standard deviation for (a) all methodologies considering all 
twenty tumours of dataset-1, (b) 3-FLAB and 3-FCM considering 2nd and 3rd classes of the ten 
heterogeneous tumours of dataset-1. 
Figure 7: Mean errors and standard deviation for each methodology, with respect to known maximum 
diameter of dataset-2 tumours. 
 
